APA (7th ed.) Citation

V, V., RC, D., T, B., V, B., E, V. N., T, V. G., . . . I, V. (2026). Value of whole-body diffusion-weighted MRI for the prediction of surgical and clinical outcome after neoadjuvant chemotherapy in advanced ovarian cancer. British journal of cancer, 134(11), 1605. https://doi.org/10.1038/s41416-026-03383-4

Chicago Style (17th ed.) Citation

V, Vandecaveye, Dresen RC, Baert T, Broeckhoven V, Van Nieuwenhuysen E, Van Gorp T, De Keyzer F, and Vergote I. "Value of Whole-body Diffusion-weighted MRI for the Prediction of Surgical and Clinical Outcome After Neoadjuvant Chemotherapy in Advanced Ovarian Cancer." British Journal of Cancer 134, no. 11 (2026): 1605. https://doi.org/10.1038/s41416-026-03383-4.

MLA (9th ed.) Citation

V, Vandecaveye, et al. "Value of Whole-body Diffusion-weighted MRI for the Prediction of Surgical and Clinical Outcome After Neoadjuvant Chemotherapy in Advanced Ovarian Cancer." British Journal of Cancer, vol. 134, no. 11, 2026, p. 1605, https://doi.org/10.1038/s41416-026-03383-4.